Fed Regist. 2010 Oct 15;75(199):63383-98.
Section 703 of the National Defense Authorization Act for Fiscal Year 2008 (NDAA-08) states with respect to any prescription filled on or after the date of enactment, the TRICARE Retail Pharmacy Program shall be treated as an element of the DoD for purposes of procurement of drugs by Federal agencies under section 8126 of title 38, United States Code (U.S.C.), to the extent necessary to ensure pharmaceuticals paid for by the DoD that are provided by network retail pharmacies under the program to eligible covered beneficiaries are subject to the pricing standards in such section 8126. DoD issued a final rule on March 17, 2009, implementing the law. On November 30, 2009, the U.S. District Court for the District of Columbia remanded the final rule to DoD (without vacating the rule) for DoD to consider in its discretion whether to readopt the current iteration of the rule or adopt another approach. This final rule is the product of that reconsideration. DoD is readopting the 2009 final rule, with some revision.
2008财年《国防授权法案》(NDAA - 08)第703节规定,对于在颁布日期或之后开具的任何处方,为确保国防部支付的药品由该计划下的网络零售药店提供给符合条件的受益对象,并使其符合美国法典第38编第8126节规定的定价标准,在联邦机构根据该节采购药品时,TRICARE零售药房计划应被视为国防部的一个组成部分。国防部于2009年3月17日发布了一项最终规则以实施该法律。2009年11月30日,美国哥伦比亚特区地方法院将该最终规则发回国防部(但未撤销该规则),由国防部自行决定是否重新采用该规则的当前版本或采用其他方法。本最终规则是该重新审议的结果。国防部正在重新采用2009年的最终规则,并做了一些修订。